Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Operating Expenses (2017 - 2025)

Inspire Medical Systems' Operating Expenses history spans 9 years, with the latest figure at $186.9 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 8.76% year-over-year to $186.9 million; the TTM value through Dec 2025 reached $727.8 million, up 13.06%, while the annual FY2025 figure was $727.8 million, 13.06% up from the prior year.
  • Operating Expenses for Q4 2025 was $186.9 million at Inspire Medical Systems, up from $183.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $186.9 million in Q4 2025 and bottomed at $50.1 million in Q1 2021.
  • The 5-year median for Operating Expenses is $142.9 million (2023), against an average of $128.5 million.
  • The largest annual shift saw Operating Expenses skyrocketed 75.48% in 2021 before it rose 8.76% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $69.1 million in 2021, then surged by 68.08% to $116.1 million in 2022, then surged by 33.66% to $155.2 million in 2023, then grew by 10.76% to $171.8 million in 2024, then rose by 8.76% to $186.9 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Operating Expenses are $186.9 million (Q4 2025), $183.1 million (Q3 2025), and $185.7 million (Q2 2025).